PACS Group Director and 10% Owner Mark Hancock Sells USD 614,250 of Common Stock

PACS Group Director and 10% Owner Mark Hancock Sells USD 1.14 Million in Common Shares

Pro Medicus Growth Not Expected to Be Impeded by Artificial Intelligence, Jefferies Says

PACS Group is Maintained at Buy by UBS

UBS Adjusts Price Target on PACS to $57 From $50, Maintains Buy Rating

PACS Group Director Mark Hancock Disposes of 161,068 Common Shares Worth $ 7.3 Million

PACS Group Inks Deal for 3,600-plus Beds Across Six States

Pacs Group to Acquire Operations of 34 Facilities Across Texas, Montana, New Mexico, North Dakota, South Dakota, and Utah

Press Release: PACS Group to Acquire Operations of 34 Facilities Across Texas, Montana, New Mexico, North Dakota, South Dakota, and Utah

PACS Group Chief Accounting Officer Michelle Renee Lewis Disposes of 15,000 Shares Worth $600,179.25

PACS Group co-founder, Exec V Chair Mark Hancock disposes of 63,680 shares worth $2.25 million

PACS Group co-founder, Exec V Chair Mark Hancock sells USD 8.4 million in common shares

Pacs Group Inc : JP Morgan Raises Target Price to $47 From $44

PACS Group Shareholders Back Board, Auditor and Compensation

PACS Group shareholders elect Dilsaver, Hancock as Class II directors at annual meeting

PACS Group Inc (PACS) Receives a Buy from Truist Financial

DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting

PACS Chief Legal Officer John Todd Mitchell sells USD 3.05 million common shares

PACS Group Is Maintained at Buy by Truist Securities